<DOC>
	<DOC>NCT00171418</DOC>
	<brief_summary>Study to assess the effects of adding tegaserod to PPI therapy results in clinically meaningful improvement of GERD symptoms in patients with incomplete relief of symptoms on daily PPI therapy alone.</brief_summary>
	<brief_title>Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Tegaserod</mesh_term>
	<criteria>GERD symptoms for at least 6 months PPI therapy for at least 4 weeks Incomplete symptom relief on daily PPI therapy No erosive disease as evidenced in EGD/no change in symptom severity Evidence of structural abnormality of the gastrointestinal tract or disease/conditions Previous gastrointestinal surgery that may influence esophageal motor function Known primary esophageal motor disorder other than Inefficient Esophageal Motor Disorder Evidence of cathartic colon or a history of laxative use Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>GERD</keyword>
	<keyword>PPI</keyword>
</DOC>